These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

205 related articles for article (PubMed ID: 38482421)

  • 1. Beginning of clinical treatment using the 1.5 Tesla MR-Linac system in Japan: a narrative review.
    Takahashi N; Tanaka S; Umezawa R; Yamamoto T; Suzuki Y; Kishida K; Omata S; Arai K; Katsuta Y; Kadoya N; Jingu K
    Transl Cancer Res; 2024 Feb; 13(2):1131-1138. PubMed ID: 38482421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Patterns of utilization and clinical adoption of 0.35 Tesla MR-guided radiation therapy in the United States - Understanding the transition to adaptive, ultra-hypofractionated treatments.
    Chuong MD; Clark MA; Henke LE; Kishan AU; Portelance L; Parikh PJ; Bassetti MF; Nagar H; Rosenberg SA; Mehta MP; Refaat T; Rineer JM; Smith A; Seung S; Zaki BI; Fuss M; Mak RH
    Clin Transl Radiat Oncol; 2023 Jan; 38():161-168. PubMed ID: 36466748
    [TBL] [Abstract][Full Text] [Related]  

  • 3. First 500 Fractions Delivered with a Magnetic Resonance-guided Radiotherapy System: Initial Experience.
    Sahin B; Zoto Mustafayev T; Gungor G; Aydin G; Yapici B; Atalar B; Ozyar E
    Cureus; 2019 Dec; 11(12):e6457. PubMed ID: 32025388
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Initial clinical experience of Stereotactic Body Radiation Therapy (SBRT) for liver metastases, primary liver malignancy, and pancreatic cancer with 4D-MRI based online adaptation and real-time MRI monitoring using a 1.5 Tesla MR-Linac.
    Hall WA; Straza MW; Chen X; Mickevicius N; Erickson B; Schultz C; Awan M; Ahunbay E; Li XA; Paulson ES
    PLoS One; 2020; 15(8):e0236570. PubMed ID: 32764748
    [TBL] [Abstract][Full Text] [Related]  

  • 5. MRI-GUIDED RADIOTHERAPY FOR PROSTATE CANCER: A NEW PARADIGM.
    Murgić J; Gregov M; Mrčela I; Budanec M; Krengli M; Fröbe A; Franco P
    Acta Clin Croat; 2022 Oct; 61(Suppl 3):65-70. PubMed ID: 36938552
    [TBL] [Abstract][Full Text] [Related]  

  • 6. MR-guidance--a clinical study to evaluate a shuttle- based MR-linac connection to provide MR-guided radiotherapy.
    Bostel T; Nicolay NH; Grossmann JG; Mohr A; Delorme S; Echner G; Häring P; Debus J; Sterzing F
    Radiat Oncol; 2014 Jan; 9():12. PubMed ID: 24401489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [MRI Connecting Functions and Anatomy: A New Bridge for Radiotherapy].
    Iima M; Iizuka Y; Matsuo Y; Takayama K; Nakamoto Y; Yamamoto A; Kataoka M; Ishimori T; Mizowaki T; Togashi K
    Igaku Butsuri; 2020; 40(1):3-7. PubMed ID: 32238681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Target coverage and dose criteria based evaluation of the first clinical 1.5T MR-linac SBRT treatments of lymph node oligometastases compared with conventional CBCT-linac treatment.
    Winkel D; Bol GH; Werensteijn-Honingh AM; Intven MPW; Eppinga WSC; Hes J; Snoeren LMW; Sikkes GG; Gadellaa-van Hooijdonk CGM; Raaymakers BW; Jürgenliemk-Schulz IM; Kroon PS
    Radiother Oncol; 2020 May; 146():118-125. PubMed ID: 32146257
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical adoption patterns of 0.35 Tesla MR-guided radiation therapy in Europe and Asia.
    Slotman BJ; Clark MA; Özyar E; Kim M; Itami J; Tallet A; Debus J; Pfeffer R; Gentile P; Hama Y; Andratschke N; Riou O; Camilleri P; Belka C; Quivrin M; Kim B; Pedersen A; van Overeem Felter M; Kim YI; Kim JH; Fuss M; Valentini V
    Radiat Oncol; 2022 Aug; 17(1):146. PubMed ID: 35996192
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transition of Online Adaptive Stereotactic Radiotherapy for Pancreatic Cancer From Magnetic Resonance-Guided Linear Accelerator (MR-Linac) to State-of-the-Art Cone-Beam Computed Tomography (CBCT).
    Rechner LA; Felter M; Bekke S; Biancardo S; Rønjom MF; Pedersen M; Sjöström D; Chen IM; Sibolt P
    Cureus; 2024 Sep; 16(9):e68386. PubMed ID: 39355470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Therapeutic Radiographers at the Helm: Moving Towards Radiographer-Led MR-Guided Radiotherapy.
    Hales RB; Rodgers J; Whiteside L; McDaid L; Berresford J; Budgell G; Choudhury A; Eccles CL
    J Med Imaging Radiat Sci; 2020 Sep; 51(3):364-372. PubMed ID: 32600981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. 4D-MRI driven MR-guided online adaptive radiotherapy for abdominal stereotactic body radiation therapy on a high field MR-Linac: Implementation and initial clinical experience.
    Paulson ES; Ahunbay E; Chen X; Mickevicius NJ; Chen GP; Schultz C; Erickson B; Straza M; Hall WA; Li XA
    Clin Transl Radiat Oncol; 2020 Jul; 23():72-79. PubMed ID: 32490218
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Case Report: MR-LINAC-guided adaptive radiotherapy for gastric cancer.
    Song Y; Zhang Y; Wang H; Zhao M; Guan F; Li Z; Yue J
    Front Oncol; 2023; 13():1159197. PubMed ID: 37746250
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Real-time motion monitoring using orthogonal cine MRI during MR-guided adaptive radiation therapy for abdominal tumors on 1.5T MR-Linac.
    Jassar H; Tai A; Chen X; Keiper TD; Paulson E; Lathuilière F; Bériault S; Hébert F; Savard L; Cooper DT; Cloake S; Li XA
    Med Phys; 2023 May; 50(5):3103-3116. PubMed ID: 36893292
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Impact of magnetic resonance-guided versus conventional radiotherapy workflows on organ at risk doses in stereotactic body radiotherapy for lymph node oligometastases.
    Werensteijn-Honingh AM; Kroon PS; Winkel D; van Gaal JC; Hes J; Snoeren LMW; Timmer JK; Mout CCP; Bol GH; Kotte AN; Eppinga WSC; Intven M; Raaymakers BW; Jürgenliemk-Schulz IM
    Phys Imaging Radiat Oncol; 2022 Jul; 23():66-73. PubMed ID: 35814260
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Magnetic-resonance-guided radiotherapy : The beginning of a new era in radiation oncology?].
    Hoegen P; Spindeldreier CK; Buchele C; Rippke C; Regnery S; Weykamp F; Klüter S; Debus J; Hörner-Rieber J
    Radiologe; 2021 Jan; 61(1):13-20. PubMed ID: 33052442
    [TBL] [Abstract][Full Text] [Related]  

  • 17. History of Technological Advancements towards MR-Linac: The Future of Image-Guided Radiotherapy.
    Rammohan N; Randall JW; Yadav P
    J Clin Med; 2022 Aug; 11(16):. PubMed ID: 36012969
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does the presence of Magtrace preclude adaptive breast radiotherapy on an MR-Linac?
    Davies LSC; McDaid L; Anandadas C; Amaro PF; Chuter R; Woolf D; Eccles CL
    J Med Imaging Radiat Sci; 2024 Dec; 55(4):101716. PubMed ID: 39032239
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Seminal vesicle intrafraction motion during the delivery of radiotherapy sessions on a 1.5 T MR-Linac.
    Muinck Keizer DM; Willigenburg T; der Voort van Zyp JRN; Raaymakers BW; Lagendijk JJW; Boer JCJ
    Radiother Oncol; 2021 Sep; 162():162-169. PubMed ID: 34293410
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The MOMENTUM Study: An International Registry for the Evidence-Based Introduction of MR-Guided Adaptive Therapy.
    de Mol van Otterloo SR; Christodouleas JP; Blezer ELA; Akhiat H; Brown K; Choudhury A; Eggert D; Erickson BA; Faivre-Finn C; Fuller CD; Goldwein J; Hafeez S; Hall E; Harrington KJ; van der Heide UA; Huddart RA; Intven MPW; Kirby AM; Lalondrelle S; McCann C; Minsky BD; Mook S; Nowee ME; Oelfke U; Orrling K; Sahgal A; Sarmiento JG; Schultz CJ; Tersteeg RJHA; Tijssen RHN; Tree AC; van Triest B; Hall WA; Verkooijen HM
    Front Oncol; 2020; 10():1328. PubMed ID: 33014774
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.